Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL) Stock Overview
Explore Castle Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
738.5M
P/E Ratio
-30.16
EPS (TTM)
$-0.83
ROE
-0.05%
CSTL Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Castle Biosciences, Inc. (CSTL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 36.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -30.16 and a market capitalization of 738.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.